Tuesday, May 15, 2018

FDA Approves Jynarque (tolvaptan) to Slow Kidney Function Decline in Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease

›
Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces that the U.S. Food and Drug Administration (FDA) has approved Jynarque ( tolvaptan ) ...
Saturday, May 12, 2018

What Does the Research Say About Coffee and Your Health?

›
In continuation of my update on coffee ... Coffee-Cup of joe. Java. No matter what you call it, millions of people worldwi...
1 comment:
Friday, May 11, 2018

FDA Approves Tavalisse (fostamatinib disodium hexahydrate) for Chronic Immune Thrombocytopenia

›
Rigel Pharmaceuticals, Inc.   announced that the U.S. Food and Drug Administration (FDA) approved  Tavalisse  (fostamatinib disodium hexah...
Thursday, May 10, 2018

Scientists successfully test anti-alcoholism drug in animal models

›
Scientists at The University of Texas at Austin have successfully tested in animals a drug that, they say, may one day help block the with...

FDA Approves Tagrisso (osimertinib) as First-Line Treatment for EGFR-Mutated Non-Small Cell Lung Cancer

›
In continuation of my update on Osimertinib ,  AstraZeneca,announced that the US Food and Drug Administration (FDA) has approved  Tagr...
Tuesday, May 8, 2018

FDA Approves Intravenous Formulation of Akynzeo (fosnetupitant/palonosetron) for Chemotherapy-Induced Nausea and Vomiting

›
Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that the U.S. Food and Drug Admini...
Tuesday, April 24, 2018

FDA Approves Erleada (apalutamide) for Non-Metastatic Castration-Resistant Prostate Cancer

›
The U.S. Food and Drug Administration, has approved  Erleada  ( apalutamide ) for the treatment of patients with prostate cancer t...
Monday, April 23, 2018

FDA Approves Symdeko (tezacaftor/ivacaftor and ivacaftor) to Treat Cystic Fibrosis in People Ages 12 and Older with Certain Mutations in the CFTR Gene

›
Vertex Pharmaceuticals Incorporated announced  the U.S. Food and Drug Administration (FDA) approval of   Symdeko  (tezacaftor/ivacaftor an...
Friday, April 20, 2018

CutisPharma Announces FDA Approval of Firvanq (vancomycin) for Treatment of Clostridium Difficile Associated Diarrhea and Staphylococcus Aureus Colitis

›
In continuation of my update on  vancomycin CutisPharma announced  the US Food and Drug Administration (FDA)  approval of  Firva...
Thursday, April 19, 2018

FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions

›
  In continuation of my update on amantadine Osmotica Pharmaceutical US LLC, announced the  U.S. Food and Drug Administration ...
Wednesday, April 18, 2018

New class of antimicrobial polymers can kill five hard-to-treat multidrug-resistant bacteria

›
An international research team led by the Institute of Bioengineering and Nanotechnology (IBN) of the Agency for Science, Technology and...
1 comment:
Monday, April 16, 2018

Antiviral drug not beneficial for reducing mother-to-child transmission of hepatitis B when added to existing preventatives

›
In continuation of my update on Tenofovir Tenofovir disoproxil fumarate (TDF), an antiviral drug commonly prescribed to treat hepatitis ...
Friday, April 13, 2018

Compound prevents neurological damage, shows cognitive benefits in mouse model of Alzheimer’s disease

›
The supplement nicotinamide riboside (NR) – a form of vitamin B3 – prevented neurological damage and improved cognitive and physical f...
Thursday, April 12, 2018

Aspirin as Good a Clot Buster as Pricey Drugs After Joint Replacement

›
Good old aspirin is just as effective as newer, expensive drugs at preventing blood clots after hip or knee replacement, a new clinical tr...